CAS 4793-24-2
:5-(Aminosulfonyl)-2-chloro-4-fluorobenzoic acid
- 5-Aminosulfonyl-2-chloro-4-fluorobenzoic acid
- 2-Chloro-4-fluoro-5-sulfamoylbenzoic acid
- 5-(Aminosulfonyl)-2-chloro-4-fluorobenzoic acid
- Benzoic acid, 2-chloro-4-fluoro-5-sulfamoyl-
- Benzoic acid, 5-(aminosulfonyl)-2-chloro-4-fluoro-
2-Chloro-4-fluoro-5-sulfamoylbenzoic acid
CAS:Formula:C7H5ClFNO4SPurity:98%Color and Shape:SolidMolecular weight:253.63532-Chloro-4-fluoro-5-sulfamoylbenzoic acid
CAS:2-Chloro-4-fluoro-5-sulfamoylbenzoic acidPurity:95%Molecular weight:253.64g/mol2-Chloro-4-fluoro-5-sulfamoylbenzoic acid
CAS:2-Chloro-4-fluoro-5-sulfamoylbenzoic acid is a sulfonamide-based compound with potential antibacterial activity to inhibit folic acid synthesis, an essential process for bacterial growth and reproduction. Additionally, the presence of the sulfamoyl group may contribute to diuretic properties, making it a candidate for treating conditions like hypertension and edema. Furthermore, this compound could exhibit antidiabetic effects by inhibiting carbonic anhydrase enzymes involved in glucose metabolism and insulin secretion, although further research is necessary to validate these applications.Formula:C7H5ClFNO4SPurity:Min. 95.5 Area-%Color and Shape:PowderMolecular weight:253.64 g/mol2-Chloro-4-fluoro-5-sulfamoylbenzoic acid
CAS:Formula:C7H5ClFNO4SPurity:98%Color and Shape:SolidMolecular weight:253.632-Chloro-4-fluoro-5-sulfamoylbenzoic Acid
CAS:Controlled ProductApplications 2-Chloro-4-fluoro-5-sulfamoylbenzoic Acid is used as a reagent in the synthesis of N-benzyl-N'-(4-piperidinyl)urea CCR5 antagonists as anti-HIV-1 agents.
References Duan, M., et al.: Bioorg. Med. Chem. Lett., 20, 7401 (2010)Formula:C7H5ClFNO4SColor and Shape:NeatMolecular weight:253.642-Chloro-4-fluoro-5-sulfamoylbenzoic acid - Bio-X ™
CAS:2-Chloro-4-fluoro-5-sulfamoylbenzoic acid is a sulfonamide-based compound with potential antibacterial activity to inhibit folic acid synthesis, an essential process for bacterial growth and reproduction. Additionally, the presence of the sulfamoyl group may contribute to diuretic properties, making it a candidate for treating conditions like hypertension and edema. Furthermore, this compound could exhibit antidiabetic effects by inhibiting carbonic anhydrase enzymes involved in glucose metabolism and insulin secretion, although further research is necessary to validate these applications.
Formula:C7H5ClFNO4SPurity:Min. 95%Color and Shape:PowderMolecular weight:253.64 g/mol





